Abiopharma

News list

Director Schall Thomas J. 🟢 acquired 21.6K shares of Immuneering Corp (IMRX) at $4.67 Transaction Date: Jan 15, 2026 | Filing ID: 000014

Full text

News bot Jan. 29, 2026, 2:19 p.m.
🔍 Schall Thomas J. (Director)

Company: Immuneering Corp (IMRX)

Report Date: 2026-01-15
Transaction Summary:
- Total transactions: 1
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 21,645
Detailed Transactions and Holdings:
- Acquired 21,645 shares of Class A Common Stock at $4.6681 per share (Direct)
  Date: 2026-01-15 | Code: P | equity_swap_involved: 0 | shares_owned_after: 74,530.00 | transaction_form_type: 4 | Footnotes: F1
Footnotes:
- F1: This transaction was executed in multiple trades through a broker-dealer at prices ranging from $4.61 to $4.69. The price reported in this column reflects the weighted average purchase price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares acquired at each price.